TRDA
TRDA clinical trials: Entrada Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Entrada Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TRDA on the catalyst calendar · TRDA registry changes
- Primary completion Mar 1, 2029Sponsor estimatePhase 1/Phase 2NCT07038824A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)RecruitingTRDALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 28, 2029Sponsor estimatePhase 1/Phase 2NCT07037862A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)RecruitingTRDALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2032Sponsor estimatePhase 2NCT07682129Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy...Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)Not yet recruitingTRDALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2025Sponsor estimateNo phase registeredNCT04245917Natural History Study of MNGIEEntrada Therapeutics, Inc. · Mitochondrial Neurogastrointestinal EncephalomyopathySuspendedTRDALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner